Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats

Metabolism: Clinical and Experimental

Volumn 45, Issue 4, 1996, Pages 457-462

  Sato, Toshiaki ^a   Nara, Yasuo ^b   Kato, Yuzuru ^b   Yamori, Yukio ^b  

^a SHIMANE UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALACEPRIL; ANTIHYPERTENSIVE AGENT; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES;

EID: 0029865285     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90219-X     Document Type: Article

References (47)

1. Fuh M, Shieh SM, Wu DA, et al: Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med 147:1035-1038, 1987
2. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
3. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39:167-174, 1990
4. Okamoto K, Aoki K: Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27:282-293, 1963
5. Yamori Y, Okamoto K: Spontaneous hypertension in the rat, a model of human "essential" hypertension, in Bergmann JF (ed): Verhandlungen der Deutschen Gesellschaft fur Innere Medizin 80. Band. Munchen, Germany, Bergmann, 1974, pp 168-170
6. Yamori Y: Pathogenesis of spontaneous hypertension as a model for essential hypertension. Jpn Circ J 41:259-266, 1977
7. Yamori Y, Ohtaka M, Ueshima H, et al: Glucose tolerance in spontaneously hypertensive rats. Jpn Circ J 42:841-847, 1978
8. Sato T, Nara Y, Kihara M, et al: Aging and dietary effect on glucose tolerance in stroke-resistant spontaneously hypertensive rats. Jpn Heart J 25:892, 1984
9. Sato T, Nara Y, Kato Y, et al: Impaired insulin metabolism in stroke-resistant spontaneously hypertensive rats and stroke-prone spontaneously hypertensive rats. Nutr Metab Cardiovasc Dis 4:155-158, 1994
10. Sato T, Nara Y, Note S, et al: Improved glucose metabolism in hypertensive diabetic rats by antihypertensive therapy. J Hypertens 4:163-165, 1986 (suppl 6)
11. Sato T, Nara Y, Note S, et al: Effect of calcium antagonists on hypertension and diabetes in new hypertensive diabetic models. J Cardiovasc Pharmacol 10:192-194, 1987 (suppl 10)
12. Sato T, Nara Y, Kato Y, et al: Beneficial effect of alacepril on glucose metabolism in both nondiabetic and diabetic spontaneously hypertensive rats (SHR), in Sassard J (ed): Proceedings of 7th International Symposium on SHR and Related Studies. Paris, France, Libbey, 1992, pp 425-427
13. Sato T, Nara Y, Kato Y, et al: Effect of high-calorie diet and streptozotocin on insulin resistance in spontaneously hypertensive rats (SHR), in Lee HK (ed): Proceedings of 7th Korea-Japan Symposium on Diabetes Mellitus. Amsterdam, The Netherlands, Elsevier, 1994, pp 381-384
14. Takeyama K, Minato H, Fukuya F, et al: Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in ranal hypertensive rats and dogs. Arzneim-Forsch Drug Res 35:1502-1507, 1985
15. Matsumoto K, Miyazaki H, Fujii T, et al: Disposition and metabolism of the novel antihypertensive agent alacepril in rats. Arzneim-Forsch Drug Res 36:40-46, 1986
16. Takeyama K, Minato F, Fukuya F, et al: Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs. Arzneim-Forsch Drug Res 35:1507-1512, 1985
17. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-873, 1989
18. Ikeda K, Nara Y, Yamori Y: Indirect systolic and mean blood pressure determination by a new tail cuff method in spontaneously hypertensive rats. Lab Anim 25:26-29, 1991
19. Huggett AS, Nixon DA: Use of glucose-oxydase peroxidase and O-dianiside in determination of blood and urinary glucose. Lancet 2:368-370, 1957
20. Morgan CR, Lazarow A: Immunoassay of insulin two antibody systems plasma insulin levels of normal subdiabetic and diabetic rats. Diabetes 12:115-122, 1963
21. Dow Chemical: Triglycerides Determination. Midland, MI, Dow Chemical, 1978
22. Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19:1350-1356, 1973
23. Lopes-Virella MF, Stone P, Ellis S, et al: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977
24. Mondon CE, Reaven GM: Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 37:303-305, 1988
25. Reaven E, Wright D, Mondon CE, et al: Effect of age and diet on insulin secretion and action in the rat. Diabetes 32:175-180, 1983
26. Reaven GM, Sageman WS, Swenson RS: Development of insulin resistance in normal dogs following alloxan-induced insulin deficiency. Diabetologia 13:459-462, 1977
27. Bevilacqua S, Barrett EJ, Smith D, et al: Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in dog. Metabolism 34:817-825, 1985
28. Lisato G, Cusin I, Tiengo A, et al: The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats. Diabetologia 35:310-315, 1992
29. Pollare T, Lithell H, Selinus, et al: Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31:415-420, 1988
30. Pollare T, Lithell H, Selinus I, et al: Sensitivity to insulin during treatment with atenolol and metoprolol: A randomized double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 298:1152-1157, 1989
31. Pollare T, Lithell H, Morlin C, et al: Metabolic effects of diltiazem and atenolol: Results from a randomized, double-blind study with parallel groups. J Hypertens 7:551-559, 1989
32. Paolisso G, Gambardella A, Verza M, et al: ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients. J Hum Hypertens 6:175-179, 1992
33. Huupponen R, Lehtonen, Vahatalo M: Effect of doxazosin on insulin sensitivity in hypertensive noninsulin dependent diabetic patients. Eur J Clin Pharmacol 43:365-368, 1992
34. Torlone E, Rambotti AM, Perriello G, et al: ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 34:119-125, 1991
35. Vuorinen-Markkola H, Koivisto VA, Yki-Jaravinen H, et al: Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes 41:571-580, 1992
36. Baron AD, Laakso M, Brechtel G, et al: Mechanism of insulin resistance in insulin-dependent diabetes mellitus: A major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 73:637-643, 1991
37. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
38. Baron AD, Laakso M, Marsh HM, et al: Reduced capacity and affinity of skeletal muscle for insulin mediated glucose uptake in non-insulin-dependent diabetic subjects. Effects of insulin therapy. J Clin Invest 87:1186-1194, 1991
39. Leren P: Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties. Am J Med 82:31-35, 1987 (suppl 1A)
40. Leren P, Eide I, Foss OP, et al: Antihypertensive drugs and blood lipids. The Oslo study. J Cardiovasc Pharmacol 4:S222-S224, 1982 (suppl 1)
41. Okun R, Kraut J: Prazosin versus captopril as initial therapy. Effect on hypertension and lipid levels. Am J Med 82:58-63, 1987 (suppl 1A)
42. Kawashima H, Igarashi T, Nakajima Y, et al: Chronic hypertension induced by streptozotocin in rats. Naunyn-Schmiedeberg's Arch Pharmacol 305:123-126, 1978
43. Igarashi T, Kawashima H, Nakajima Y, et al: Hypertension induced by streptozotocin or alloxan in the rat, in Yamori Y, Lovenberg W, Freis ED (eds): Prophylactic Approach to Hypertensive Disease. New York, NY, Raven, 1979, pp 277-282
44. Somani P, Singh HP, Saini PK, et al: Streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism 28:1075-1077, 1979
45. Fluckiger W, Perrin IV, Rossi GL: Morphometric studies on retinal microangiography and myocardiopathy in hypertensive rats (SHR) with induced diabetes. Virchows Arch [Cell Pathol] 47:79-94, 1984
46. Sato T, Nara Y, Kato Y, et al: Hypertensive diabetic rats: Different effects of streptozotocin treatment on blood pressure in adult SHR and in neonatal SHR. Clin Exp Hypertens [A] 13:981-990, 1991
47. Greenfield MS, Doberne L, Kraemer F, et al: Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30:387-392, 1981